Cytori Therapeutics, Inc. (CYTX) is “One to Watch”
Cytori has developed technology designed to assist the physician in reconstructive and aesthetic surgery procedures. The company’s mission is to improve the quality and length of life by providing innovative regenerative therapies to patients. Their key technology is the Celution® 700 system that prepares an autologous tissue graft for delivery back to the patient in the same surgical procedure. Although Celution® is currently unavailable in the U.S., the technology is under review by the US Food and Drug Administration (FDA) and commercially available in many countries in Europe and Asia. Cytori is actively pursuing the expansion of their distributor network…